Switch to:
More From Other Websites
New competition is coming for Mylan’s EpiPen next year. But will the price be right? Oct 26 2016
EpiPen Competitor Will Re-Launch After Being Pulled Off Market Oct 26 2016
First Eagle Investments Comments on Sanofi Oct 24 2016
First Eagle Global Value Team 3rd Quarter Commentary Oct 24 2016
What to Watch in Sanofi's Third-Quarter Results Oct 24 2016
Eli Lilly, AbbVie Top 2017 Rankings; Pfizer, AstraZeneca Flailing Oct 17 2016
Moody's: French bond issuance volumes to be resilient in 2017, as large and repeat issuers will... Oct 17 2016
Is iBPMS the Secret Ingredient for Agile Digital Transformation? Oct 13 2016
Availability of the Pre-quarterly Results Communication ? Oct 12 2016
Sanofi Vaccines Unit Riding High on BARDA Zika Funding Oct 11 2016
Gilead's Patience Is Wearing Investors' Patience Thin Oct 10 2016
[$$] Insulin Prices Soar While Drugmakers’ Share Stays Flat Oct 09 2016
[$$] Insulin-Price Increases Reflect Role of Health-Care Middlemen Oct 07 2016
BioMarin, Incyte, Kite Get Thumbs Up On Goldman Sachs Upgrade Oct 07 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)